VIVUS
About:
VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products
Website: http://www.vivus.com
Top Investors: Deerfield, OrbiMed, Franklin Templeton, Frazier Healthcare Partners, Domain Associates
Description:
VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity, diabetes, sleep apnea and sexual health.
Total Funding Amount:
$53.6M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Mountain View, California, United States
Founded Date:
1991-01-01
Contact Email:
sunshineact(AT)vivus.com
Founders:
Number of Employees:
51-100
Last Funding Date:
2020-11-20
IPO Status:
Public
Industries:
© 2025 bioDAO.ai